ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

Zota Healthcare Earnings Call: Key Takeaways

Zota Health Care (FY26) achieved ₹53,865.75 lakhs revenue, driven by its Davaindia generic pharmacy retail chain which now spans 2,579 stores across 23 states.

Highlights
Revenue growthFY26 consolidated revenue ₹53,865.75 lakhs.
MarginsDavaindia COCO format maintains ~60% gross margin.
Demand visibilityStrong, driven by 30-90% consumer savings on generic medicines.
Management confidenceHigh; expanding store network and appointing high-profile brand ambassadors.

Growth

FY26 Revenue: ₹53,865.75L; Gross Profit: ₹32,468.90L; EBITDA: ₹2,597.73L; Davaindia GMV: ₹45,706L.

Outlook

Expanding COCO/FOFO network; leveraging 87.78% stake in Everyday Herbal Group for backward integration into OTC segments.

Risks

Regulatory changes in pharma policies and competitive intensity in the generic retail pharmacy sector.

Source

Earnings Call filed with NSE, NSE: ZOTA. Summary written with AI assistance from the document.

Read the document ↗

Zota Healthcare Ltd: key numbers

Share price
₹1,327.30
Market cap
₹4,597 Cr
Revenue (annual)
₹538.7 Cr
Net profit (annual)
₹-73.94 Cr
P/E (TTM)
-40.8×Sector 43.8×
Promoter holding
49.38%+0.00% QoQ
FII holding
6.92%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Zota Healthcare Ltd

All →